How has AptarGroup's common stock, shares authorized (in shares) changed year-over-year?

AptarGroup's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $199M to $199M.

What is the long-term trend for AptarGroup's common stock, shares authorized (in shares)?

Over 5 years (2020 to 2025), AptarGroup's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $199M to $199M.

AptarGroup ATR Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

West Pharmaceutical ServicesWST

——

AmcorAMCR

——

Baxter InternationalBAX

——

Halozyme TherapeuticsHALO

——

Becton, Dickinson and CompanyBDX

——

DuPont de Nemours, Inc.DD

——

Other financials

Income statement

See full

Revenue$982.9M+10.8%

Gross profit$351.9M+4.6%

Operating income$107.5M-5.2%

Net income$72.7M-7.8%

EPS (diluted)$1.12-4.3%

Balance sheet

See full

Cash & equivalents$225.0M+78.8%

Total debt$1.4B+32.7%

Total equity$2.6B+3.6%

Total assets$5.1B+12.6%

Cash flow

See full

Operating cash flow$118.7M+43.5%

CapEx$65.4M+15.0%

Free cash flow$53.3M+106%

Valuation

See full

Market cap$7.68B-17.9%

Enterprise value$8.89B-13.9%

P/E19.9×-5.4×

P/S2×-0.6×

Profitability

See full

Gross margin36.7%-1.6pp

Operating margin12.8%-1.2pp

Net margin10%-0.4pp

FCF margin8.4%-2.1pp

Returns & leverage

See full

Return on equity15%-0.2pp

Debt / equity0.5×+0.1×

Current ratio1.7×+0.4×

Where this comes from

Reported directly by AptarGroup in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: AptarGroup’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about AptarGroup's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AptarGroup's common stock, shares authorized (in shares)?: AptarGroup (ATR) reported common stock, shares authorized (in shares) of $199M in Q1 2026.
How has AptarGroup's common stock, shares authorized (in shares) changed year-over-year?: AptarGroup's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $199M to $199M.
What is the long-term trend for AptarGroup's common stock, shares authorized (in shares)?: Over 5 years (2020 to 2025), AptarGroup's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $199M to $199M.